Pham Quang X (CIK 0001405290)

Latest company ownership

Shares held
200,000
Last filed at
Oct 28, 2025
Confidence Score
43.0
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 24, 2025 Oct 28, 2025 Cadrenal Therapeutics, Inc. CEO Sell 51.3 -2,444 -0.61% ✓ $34.2K
Oct 9, 2025 Oct 14, 2025 Cadrenal Therapeutics, Inc. CEO Sell 47.5 -3,600 -0.90% ✓ $50.7K
Oct 2, 2025 Oct 3, 2025 Cadrenal Therapeutics, Inc. CEO Sell 55.0 -500 -0.12% ✓ $7.1K
Sep 29, 2025 Oct 1, 2025 Cadrenal Therapeutics, Inc. CEO Sell 52.5 -1,300 -0.32% ✓ $18.2K
Sep 24, 2025 Sep 26, 2025 Cadrenal Therapeutics, Inc. CEO Sell 22.5 -9,371 -2.27% ✗ $131.8K
Aug 27, 2025 Aug 29, 2025 Cadrenal Therapeutics, Inc. CEO Sell 22.5 -5,029 -1.20% ✗ $70.4K
Sep 5, 2023 Sep 6, 2023 Cadrenal Therapeutics, Inc. CEO Buy 68.8 +40,000 0.63% ✗ $36.2K
Sep 1, 2023 Sep 5, 2023 Cadrenal Therapeutics, Inc. CEO Buy 82.5 +70,000 1.11% ✗ $63.9K